Add BrightSurf on Google Email

New approach to treatment of deadly kidney cancer

A new study from Karolinska Institutet has identified a key mechanism behind treatment resistance in a deadly form of kidney cancer. By increasing mitochondrial content in cancer cells, researchers found that these cells became susceptible to the cancer drug sorafenib. This breakthrough offers hope for more targeted cancer treatments.

SourceKarolinska Institutet·JournalNature Metabolism·DateJun 27, 2022

Stop for migration!

Researchers at Nagoya City University found that glycerol phosphate modification terminates matriglycan elongation, disrupting cell adhesion and promoting cancer cell migration. Enhanced GroP modification is correlated with increased PCYT2 expression in colorectal cancer tissue.

SourceNagoya City University·JournalInternational Journal of Molecular Sciences·TypeExperimental study·DateJun 24, 2022

Porous cells lead to poorer livers

Researchers discovered that porous cell membrane formation allows cancer-inducing proteins to escape and promote tumor growth in nonalcoholic steatohepatitis-associated liver cancer. The release of IL-33 and IL-1β from senescent hepatic stellate cells accelerates cancer development by suppressing anti-tumor immunity.

SourceOsaka Metropolitan University·JournalScience Immunology·TypeExperimental study·DateJun 24, 2022

App to help doctors help patients with leukemia

Researchers have developed an app to help doctors identify patients with chronic lymphocytic leukemia (CLL) at risk of developing infections, allowing for earlier treatment. The app uses blood test results and genetic data to predict patient risk, improving treatment outcomes and reducing pressure on the healthcare system.

SourceUniversity of Copenhagen - The Faculty of Health and Medical Sciences·JournalCommunications Medicine·TypeCase study·DateJun 24, 2022

Study highlights undiscovered potential of bacterial compounds and genes linked to colon cancer-related toxin

A team of scientists has developed a novel computational approach to analyze DNA sequences of thousands of bacteria, revealing previously unknown gene clusters responsible for producing metabolites of interest. The study highlights the potential of these bacterial compounds in treating colon cancer and improving treatment options.

SourceKeAi Communications Co., Ltd.·JournalSynthetic and Systems Biotechnology·TypeComputational simulation/modeling·DateJun 21, 2022

JNCCN: Mismatch in breast cancer trial results and real-world outcomes based on treatment discontinuation

A population-based study found that patients with estrogen receptor-positive breast cancer who experienced hot flashes while on adjuvant hormone therapy had worse outcomes and a higher risk of early treatment discontinuation. The study suggests that managing side effects may not be enough to prevent treatment discontinuation, highlight...

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·TypeData/statistical analysis·DateJun 21, 2022

Unveiling the mysteries of the genome structure in the human cell nucleus using a 3D computational simulation

Researchers at Nagoya University created a 3D model of the human genome structure, analyzing its dynamics and functions. The study provides new insights into chromatin distribution, cell division, and transcription regulation, shedding light on cellular processes and potential disease mechanisms.

SourceNagoya University·JournalProceedings of the National Academy of Sciences·DateJun 20, 2022

Virtual CT scans cut patient radiation exposure in half during PET/CT studies

Researchers developed an artificial intelligence method to generate high-quality 'PET/CT' images, reducing radiation exposure and allowing for more frequent imaging. This innovation has the potential to provide more accurate assessment of disease progression and treatment efficacy, ultimately improving patient care.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJun 12, 2022

Oncotarget | A novel group of genes that cause endocrine resistance in breast cancer identified by dynamic gene expression analysis

A recent study identified 34 novel genes that contribute to endocrine resistance in breast cancer using dynamic gene expression analysis. The researchers found that these genes are differentially expressed in both estrogen receptor-positive and triple-negative breast cancers, suggesting shared genetic mechanisms underlying resistance d...

SourceImpact Journals LLC·JournalOncotarget·TypeComputational simulation/modeling·DateJun 8, 2022

"Bridge therapy” may benefit some children with high-risk neuroblastoma

Researchers found that a bridge therapy approach prior to consolidation therapy can improve event-free survival in patients with stable metastatic cancer after induction therapy. Patients who received this treatment had significantly better outcomes compared to those who underwent direct consolidation or post-induction therapy alone.

SourceWiley·JournalCancer·TypeRandomized controlled/clinical trial·DateJun 6, 2022

Using telehealth to regularly report symptoms improved overall well-being for patients with advanced cancer

A multi-state study found that patients with advanced cancer who reported symptoms weekly using an electronic survey had better physical function and symptom control compared to those evaluated less frequently. The study showed a 35% better ability to function physically, a 16.1% better control of symptoms, and a 41% better overall hea...

SourceUNC Lineberger Comprehensive Cancer Center·JournalJAMA·TypeRandomized controlled/clinical trial·DateJun 6, 2022

Graphic warnings on cigarette labels led smokers to hide packs

A randomized clinical trial found that smokers who received cigarette packs with graphic warning labels hid their packs 38% more often. However, when they returned to regular packs without the labels, hiding behavior returned to baseline levels. The study suggests that graphic warnings may not be effective in reducing smoking behavior.

SourceUniversity of California - San Diego·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateJun 2, 2022

Meta-analysis shows targeted radiation therapy may be as effective as standard care for small cell lung cancer patients with brain metastases

A meta-analysis published in The Lancet Oncology suggests that targeted radiation therapy, which spares healthy brain tissue, is equitable to whole brain radiation therapy for patients with small cell lung cancer and brain metastases. This approach may improve their care experience with fewer negative cognitive consequences.

SourceSt. Michael's Hospital·JournalThe Lancet Oncology·TypeMeta-analysis·DateMay 27, 2022

Not individual genes but the “mutational signatures” of many genes hold the key to better cancer therapies

Researchers have found that mutational signatures, which reflect a collection of mutations across the genome, can accurately predict drug response in cancer cells. The study suggests that these signatures may hold the key to better cancer therapies and could be used to predict treatment response.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature Communications·TypeComputational simulation/modeling·DateMay 26, 2022

People in rural communities face cultural, structural and individual barriers to health care

A systematic review of qualitative studies found that rural patients experience significant challenges in accessing health care services for chronic conditions. Cultural, structural, and individual factors influence these experiences, highlighting the need for culturally appropriate interventions to improve access to care.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateMay 24, 2022

If you take several medications, ‘polypharmacy’ is a word to know

A recent study found that 70% of adults with stage 3 or 4 cancer were at risk of drug-drug interactions, highlighting the importance of deprescribing medications to avoid harm. The study's results emphasize the need for education and problem-solving to address polypharmacy in older adults with cancer.

SourceUniversity of Rochester Medical Center·JournalThe Oncologist·TypeRandomized controlled/clinical trial·DateMay 17, 2022

Gwangju Institute of Science and Technology researchers develop a tool for studying inflammatory diseases related to COVID-19

Researchers at Gwangju Institute of Science and Technology have developed a new bioinformatics pipeline, CRESSP, to investigate the mechanism underlying autoimmune diseases following SARS-CoV-2 infection. The tool identified potential epitopes responsible for COVID-related autoimmune diseases and predicted cross-reactive epitopes of di...

SourceGIST (Gwangju Institute of Science and Technology)·JournalBriefings in Bioinformatics·TypeComputational simulation/modeling·DateMay 16, 2022

Early days of COVID-19 pandemic brought increased anxiety for some cancer survivors

A recent study found that previous therapy interventions, including ACT, did not spare cancer survivors from increased anxiety during the COVID-19 pandemic. Researchers found that anxiety symptoms worsened over time, with participants who received ACT intervention performing worse than those who received usual care.

SourceUniversity of Colorado Anschutz Medical Campus·JournalJournal of Contextual Behavioral Science·TypeSurvey·DateMay 16, 2022

First mutation-targeted bladder cancer drug may be under-used

A recent study analyzed a large database of bladder cancer patients and found that fewer than half had been tested for the relevant gene mutation or received erdafitinib treatment, despite its proven efficacy. The research highlights significant barriers to treatment, including obstacles in testing and education for healthcare providers.

SourceUniversity of Pennsylvania School of Medicine·JournalJAMA Oncology·TypeContent analysis·DateMay 12, 2022

New research in JNCCN encourages harnessing health technology to help cancer patients quit smoking

A new study published in the Journal of the National Comprehensive Cancer Network (JNCCN) found that incorporating the Electronic Health Record-Enabled Evidence-Based Smoking Cessation Treatment (ELEVATE) program into electronic health records can significantly improve smoking cessation rates among cancer patients. The research demonst...

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·TypeData/statistical analysis·DateMay 11, 2022

New study reviews anti-cancer activity of sustained release capsaicin formulations

A recent study published in Pharmacology & Therapeutics provides an in-depth description of the anti-cancer activity of sustained release capsaicin formulations. The research team found that capsaicin displayed robust growth-inhibitory activity in a diverse array of human cancers, but its clinical applications were hindered by poor sol...

SourceMarshall University Joan C. Edwards School of Medicine·JournalPharmacology & Therapeutics·TypeLiterature review·DateMay 4, 2022